FY2027 Earnings Forecast for ISRG Issued By Erste Group Bank

Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) – Analysts at Erste Group Bank lowered their FY2027 EPS estimates for Intuitive Surgical in a report released on Wednesday, July 15th. Erste Group Bank analyst H. Engel now expects that the medical equipment provider will post earnings of $9.91 per share for the year, down from their previous estimate of $9.94. The consensus estimate for Intuitive Surgical’s current full-year earnings is $8.61 per share.

Other equities research analysts have also issued reports about the company. HSBC cut their target price on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Citigroup decreased their price target on Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a research report on Friday, July 17th. Leerink Partners dropped their price target on Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating on the stock in a research note on Friday, July 17th. The Goldman Sachs Group set a $558.00 price objective on Intuitive Surgical in a report on Wednesday, May 27th. Finally, Barclays set a $651.00 price objective on shares of Intuitive Surgical and gave the company an “overweight” rating in a research note on Thursday, April 23rd. Twenty-one equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $523.46.

Read Our Latest Analysis on Intuitive Surgical

Intuitive Surgical Stock Down 0.9%

ISRG opened at $350.06 on Monday. The firm has a market cap of $123.98 billion, a PE ratio of 40.10, a P/E/G ratio of 2.72 and a beta of 1.46. The business has a fifty day simple moving average of $412.30 and a 200-day simple moving average of $464.06. Intuitive Surgical has a fifty-two week low of $342.10 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last posted its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 17.09% and a net margin of 28.45%.The company had revenue of $2.89 billion for the quarter, compared to analysts’ expectations of $2.83 billion. During the same quarter in the prior year, the company earned $1.81 earnings per share. The firm’s revenue was up 18.4% on a year-over-year basis.

Insider Activity

In other news, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the transaction, the executive vice president owned 5,720 shares in the company, valued at approximately $2,426,080.80. The trade was a 6.54% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of the company’s stock in a transaction on Wednesday, April 29th. The shares were sold at an average price of $463.50, for a total value of $55,156.50. Following the transaction, the director directly owned 120 shares in the company, valued at $55,620. The trade was a 49.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,169 shares of company stock worth $3,059,135 over the last quarter. Corporate insiders own 0.60% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

A number of institutional investors have recently bought and sold shares of the business. Regent Peak Wealth Advisors LLC grew its stake in Intuitive Surgical by 7.2% during the 2nd quarter. Regent Peak Wealth Advisors LLC now owns 800 shares of the medical equipment provider’s stock valued at $318,000 after acquiring an additional 54 shares in the last quarter. Hyperion Asset Management Ltd increased its holdings in shares of Intuitive Surgical by 49.8% in the 2nd quarter. Hyperion Asset Management Ltd now owns 419,329 shares of the medical equipment provider’s stock valued at $166,759,000 after purchasing an additional 139,422 shares during the period. Northside Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the second quarter worth approximately $669,000. Annex Advisory Services LLC lifted its position in shares of Intuitive Surgical by 37.4% in the second quarter. Annex Advisory Services LLC now owns 90,943 shares of the medical equipment provider’s stock worth $36,166,000 after purchasing an additional 24,750 shares in the last quarter. Finally, Tema ETFs LLC boosted its holdings in shares of Intuitive Surgical by 28.8% during the second quarter. Tema ETFs LLC now owns 9,704 shares of the medical equipment provider’s stock worth $3,859,000 after purchasing an additional 2,170 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

  • Positive Sentiment: Recent commentary highlights that Intuitive Surgical’s latest earnings were impressive, with the company continuing to post strong growth and beating expectations, which supports the long-term investment case. Article Title
  • Positive Sentiment: Analysts and recent coverage argue the stock may be oversold, with Wall Street estimate revisions moving higher and some writers saying the pullback could create a buying opportunity for growth investors. Article Title
  • Positive Sentiment: One valuation-focused piece says ISRG is being priced for slower growth than it is currently delivering, suggesting the stock could be undervalued if the company maintains its current pace. Article Title
  • Neutral Sentiment: Multiple articles note that ISRG has become a heavily watched and widely discussed stock, reflecting heightened investor attention rather than a clear new business catalyst. Article Title
  • Negative Sentiment: Despite the strong fundamentals, the stock has fallen sharply over the past several weeks, and several reports frame the decline as a correction driven by investor caution around valuation and recent price weakness. Article Title

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Recommended Stories

Earnings History and Estimates for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.